Erratum: p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors (Cancer Cell (2019) 35(2) (204–220.e9), (S1535610819300406), (10.1016/j.ccell.2019.01.006))

(Cancer Cell 35, 204–220, February 11, 2019) We, the authors of this publication, reported that inactivation of the tumor suppressor gene SMARCB1 drives increased protein metabolism and proteotoxic stress in malignant rhabdoid tumors, sensitizing them to agents inducing proteotoxic stress and autophagy inhibition. We have identified several errors in the published figures. Specifically, the transmission electron microscopy (TEM) image for the shMyc group in Figure 4H was duplicated from the image for the Smarcb1Δ/Δ-pLIX-iSMARCB1 +DOX group in Figure 1I. The p53 western blot panel in Figure 4I was duplicated from the MYC western blot panel in Figure S4C. Furthermore, the pEIF2a immunohistochemistry image from the tamoxifen (Tx) group in Figure S5B was duplicated from the shDram1-2 group in Figure S6E. These errors were inadvertently introduced during the preparation of the figures and do not alter the results or conclusions of the study. We now provide the corrected Figures 4 and S5 and sincerely apologize for any confusion these errors may have caused.[Figure presented][Figure presented]